Phase 1 study of selinexor plus mitoxantrone, etoposide, and cytarabine in acute myeloid leukemia.

被引：6

作者：

Bhatnagar, Bhavana

Walker, Alison R.

Mims, Alice S.

Vasu, Sumithira

Klisovic, Rebecca B.

Behbehani, Gregory

Blachly, James Stewart

Larkin, Karilyn T. M.

Long, Meixiao

Zhao, Qiuhong

Ranganathan, Parvathi

Byrd, John C.

Blum, William G.

Garzon, Ramiro

机构：

[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[2] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA

[3] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[4] Ohio State Univ, Columbus, OH 43210 USA

[5] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA

[6] Ohio State Univ, Div Hematol, Columbus, OH 43210 USA

来源：

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.7048

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

7048

引用

页数：2